Feb 2004;13(2):205-12
This will ensure that you choose the correct type and avoid any potential risks associated with its use
GLP-1 and GLP-1 RA (such as Exenatide and Liraglutide) were shown to have an anti-inflammatory action by reducing monocyte adhesion and macrophage accumulation, thus stabilizing atherosclerotic plaque, and slowing atherosclerosis in animal models [47,48,49]
(2) optimization of combination therapy strategies with established anticancer agents [13, 18, 31, 33, 97, 127,128,129]
doi: 10.1016/j.yexcr.2023.113614 Summary Keywords Tregs, Foxo, AMPK pathway, SGLT2I, GLP1-RAs, inflammation, type 2 diabetes Citation Mazzieri A, Basta G, Calafiore R and Luca G (2023) GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway
A.WarrenJ